Epigenomics AG Namens-Aktien o.N.
- BID
0.95
- ASK
1
- 1,500 Units1,500 Units
- 07/21, 21:58:50 PM
Sector and Industry
Business Services, Business Services
Performance (1Y)
13.83%
Market Cap
1.04 Mil.
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-0.35 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Palantir Technologies Inc. | 361.90 Bil. | 3.97 Bil. | 280.58 | +237.12 % | 0.00 | - |
| Automatic Data Processing Inc. | 106.48 Bil. | 18.91 Bil. | 30.90 | +8.17 % | 0.00 | - |
| Moodys Corp | 77.23 Bil. | 6.84 Bil. | 37.37 | +14.57 % | 0.00 | - |
| Marsh LLC | 76.59 Bil. | 23.95 Bil. | 22.03 | -1.76 % | 0.00 | - |
| Waste Management Inc. | 75.38 Bil. | 22.34 Bil. | 32.79 | -5.44 % | 0.00 | - |
| Cintas Corp | 58.73 Bil. | 9.66 Bil. | 34.88 | +2.65 % | 0.00 | - |
| Republic Services Inc. | 55.58 Bil. | 14.71 Bil. | 30.93 | +0.39 % | 0.00 | - |
| Waste Connections Inc | 38.22 Bil. | 8.39 Bil. | 41.28 | +67.13 % | 0.00 | - |
| Fair Isaac Corp. | 30.27 Bil. | 1.80 Bil. | 56.38 | +24.88 % | 0.00 | - |
| Kuaishou Technology Class B | 30.22 Bil. | 17.61 Bil. | 13.56 | +16.55 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 0.95 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 09:55:54 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 0.95 | 0.95 |
| PREV. DAY'S PRICE | 0.95 | (07/20) |
| CHANGE DAY BEFORE | +0.00 | 0.00 % |
| 52 WEEK HIGH / LOW | 1.5611 (11/12) | 0.8149 (06/11) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026 | 2027 | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -5.14 | -3.75 | -0.35 | - | - |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | - | - |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | - | - | - |
PRICE - BOOK RATIO | - | - | - | - | - |
PRICE - SALES RATIO | 4.75 | - | 32.89 | - | - |
PRICE - CASH FLOW RATIO | - | - | - | - | - |
Master Data
| WKN | A37FT4 |
| ISIN | DE000A37FT41 |
| SYMBOL | ECX |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | EPIGENOMICS AG NA O.N. |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Business Services, Business Services |
| NUMBER OF SHARES | 1.10 Mil. |
| MARKET CAPITALISATION | 1.04 Mil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 9.20 % | 11.22 % | 5.17 % | 7.51 % | 13.83 % | 46.60 % | -20.17 % | 7.51 % |
| HIGH | 0.98 | 1.38 | 1.38 | 1.45 | 1.56 | 2.44 | 2.44 | 1.45 |
| LOW | 0.88 | 0.85 | 0.81 | 0.81 | 0.81 | 0.41 | 0.29 | 0.81 |
Dividende
pro Aktie
EPIGENOMICS AG NA O.N. does not deliver dividend information
Company profile
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. It offers Epi proColon, a blood-based test for the early detection of colorectal cancer; Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer, Epi BiSKit, a kit for the preparation of purified, bisulfite-converted DNA and, HCCBloodTest, a blood test for cirrhotic patients at high-risk for the development of hepatocellular carcinoma. The company was founded by Oliver Schacht, Christian Piepenbrock, Kurt Berlin, Jörn Walter, and Ivo G. Gut in 1998 and is headquartered in Berlin, Germany.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
(in 22 days)
08/12/26Q2 2026 Earnings Release